Is Aerpio Pharmaceuticals, Inc. (ARPO) a Buy, Sell, or Hold?
NASDAQ : ARPO
Aerpio Pharmaceuticals, Inc.
$2.2 USD
-$0.02 (-0.9%)
- Volume
- 826.01K
- Average Volume
- 401.78K
- Market Capitalization
- $53.67M
- P/E Ratio
- -1.31
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $49.80
- Year Low
- $2.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.36
Insider Activity Summary (Last 12 Months)
Insiders Buying
0
Insiders Selling
0
Amount of Insider Selling
-$
ARPO Insider Buying/Selling by Quarter
ARPO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Dalal Anupam | director | 2021-06-30 | A-Award | 1.52 | 2021-07-02 |
| Castelein Caley | director | 2021-06-30 | A-Award | 1.52 | 2021-07-02 |
| Cohen Cheryl | director | 2021-06-30 | A-Award | 1.52 | 2021-07-02 |
| Cohen Cheryl | director | 2021-06-17 | A-Award | 1.87 | 2021-06-22 |
| Cohen Cheryl | director | 2021-03-31 | A-Award | 1.543 | 2021-04-02 |
| Dalal Anupam | director | 2021-03-31 | A-Award | 1.543 | 2021-04-02 |
| Castelein Caley | director | 2021-03-31 | A-Award | 1.543 | 2021-04-02 |
| Cohen Cheryl | director | 2021-02-01 | A-Award | 1.46 | 2021-02-03 |
| Castelein Caley | director | 2021-02-01 | A-Award | 1.46 | 2021-02-03 |
| Dalal Anupam | director | 2021-02-01 | A-Award | 1.46 | 2021-02-03 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2020-12-08 | X-InTheMoney | 0.96 | 2020-12-10 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2020-12-08 | X-InTheMoney | 0.96 | 2020-12-10 |
| ORBIMED ADVISORS LLC | 10 percent owner | 2020-12-08 | S-Sale | 1.96 | 2020-12-10 |
| Dalal Anupam | director | 2020-06-24 | A-Award | 1.22 | 2020-06-26 |
| Castelein Caley | director | 2020-06-24 | A-Award | 1.22 | 2020-06-26 |
| Cohen Cheryl | director | 2020-06-24 | A-Award | 1.22 | 2020-06-26 |
| Gardner Joseph H. | director, officer: President | 2020-03-16 | A-Award | 0.5201 | 2020-03-18 |
| PETERS KEVIN G. | officer: See Remarks | 2020-03-16 | A-Award | 0.5201 | 2020-03-18 |
| Gardner Joseph H. | director, officer: President | 2019-07-10 | P-Purchase | 0.8147 | 2019-07-10 |
| Gardner Joseph H. | director, officer: President | 2019-07-03 | P-Purchase | 0.897 | 2019-07-08 |
| Dalal Anupam | director | 2019-06-18 | A-Award | 0.96 | 2019-06-19 |
| Castelein Caley | director | 2019-06-18 | A-Award | 0.96 | 2019-06-19 |
| Khuong Chau Quang | director, 10 percent owner: | 2019-06-18 | A-Award | 0.96 | 2019-06-19 |
| Cohen Cheryl | director | 2019-06-18 | A-Award | 0.96 | 2019-06-19 |
| Gardner Joseph H. | director, officer: President | 2019-05-14 | A-Award | 1.04 | 2019-05-16 |
| PETERS KEVIN G. | officer: See Remarks | 2019-05-14 | A-Award | 1.04 | 2019-05-16 |
| PETERS KEVIN G. | officer: See Remarks | 2019-05-14 | A-Award | 1.04 | 2019-05-16 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-25 | S-Sale | 1.03 | 2019-04-29 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-26 | S-Sale | 1.03 | 2019-04-29 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-22 | S-Sale | 0.97 | 2019-04-24 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-23 | S-Sale | 1.03 | 2019-04-24 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-24 | S-Sale | 1.03 | 2019-04-24 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-11 | S-Sale | 1.08 | 2019-04-15 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-12 | S-Sale | 1.04 | 2019-04-15 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-15 | S-Sale | 0.99 | 2019-04-15 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-08 | S-Sale | 1.02 | 2019-04-10 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-09 | S-Sale | 1.01 | 2019-04-10 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-10 | S-Sale | 1.09 | 2019-04-10 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-03 | S-Sale | 0.96 | 2019-04-05 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-04 | S-Sale | 1.01 | 2019-04-05 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-05 | S-Sale | 1.02 | 2019-04-05 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-03-29 | S-Sale | 0.91 | 2019-04-02 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-01 | S-Sale | 0.95 | 2019-04-02 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-04-02 | S-Sale | 0.97 | 2019-04-02 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-03-26 | S-Sale | 1.01 | 2019-03-28 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-03-27 | S-Sale | 0.99 | 2019-03-28 |
| Novartis Bioventures Ltd | 10 percent owner | 2019-03-28 | S-Sale | 0.94 | 2019-03-28 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2019-02-15 | A-Award | 3.27 | 2019-02-20 |
| Gardner Joseph H. | director, officer: President | 2019-02-15 | A-Award | 3.27 | 2019-02-20 |
| PETERS KEVIN G. | officer: Chief Scientific Officer | 2019-02-15 | A-Award | 3.27 | 2019-02-20 |
| Gardner Joseph H. | director, officer: President | 2018-12-31 | 0 | 2019-02-13 | |
| Castelein Caley | director | 2018-09-24 | J-Other | 0 | 2018-09-26 |
| Castelein Caley | director | 2018-09-24 | D-Return | 0 | 2018-09-26 |
| Novartis Bioventures Ltd | 10 percent owner | 2018-08-20 | S-Sale | 3.9 | 2018-08-22 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | 2018-06-28 | P-Purchase | 3.85 | 2018-07-02 |
| Khuong Chau Quang | director, 10 percent owner: | 2018-06-28 | P-Purchase | 3.85 | 2018-07-02 |
| Dalal Anupam | director | 2018-06-20 | A-Award | 4 | 2018-06-22 |
| Khuong Chau Quang | director | 2018-06-20 | A-Award | 4 | 2018-06-22 |
| Castelein Caley | director | 2018-06-20 | A-Award | 4 | 2018-06-22 |
| Cohen Cheryl | director | 2018-06-20 | A-Award | 4 | 2018-06-22 |
| Cohen Cheryl | director: | 2018-06-20 | 0 | 2018-06-22 | |
| PETERS KEVIN G. | officer: Chief Scientific Officer | 2018-04-23 | A-Award | 3.59 | 2018-04-25 |
| PAKOLA STEVE | officer: Chief Medical Officer | 2018-04-23 | A-Award | 3.59 | 2018-04-25 |
| Gardner Joseph H. | director, officer: President | 2018-04-23 | A-Award | 3.59 | 2018-04-25 |
| Castelein Caley | director: | 2017-12-31 | 0 | 2018-02-14 | |
| Dalal Anupam | director: | 2017-12-31 | 0 | 2018-02-14 | |
| Gardner Joseph H. | director, officer: President | 2017-12-14 | A-Award | 5.5 | 2017-12-18 |